Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

260 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 12, 2026Aug 13 9:09 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$515.03$4.9M324,443(I)

View →

Aug 11, 2026Aug 12 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$522.87$5.0M324,443(I)

View →

Aug 10, 2026Aug 11 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$530.11$5.0M324,443(I)

View →

Aug 7, 2026Aug 10 8:38 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$531.38$5.0M324,443(I)

View →

Aug 6, 2026Aug 7 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$525.36$5.0M324,443(I)

View →

Aug 6, 2026Aug 6 8:35 PMPaul A MahonEVP & GENERAL COUNSEL
Sale
8,300$517.05$4.3M45,172(D)

View →

Aug 5, 2026Aug 6 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$518.74$4.9M324,443(I)

View →

Aug 6, 2026Aug 6 8:02 PMPAUL MAHON
Proposed Sale
8,300$517.05$4.3M—

View →

Aug 4, 2026Aug 5 8:36 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$517.09$4.9M324,443(I)

View →

Aug 3, 2026Aug 4 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$516.06$4.9M324,443(I)

View →

Aug 3, 2026Aug 3 8:41 PMMARTINE ROTHBLATT
Proposed Sale
199,500$517.71$103.3M—

View →

Jul 31, 2026Aug 3 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$518.96$4.9M324,443(I)

View →

Jul 30, 2026Jul 31 8:18 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$524.90$5.0M324,443(I)

View →

Jul 29, 2026Jul 30 11:58 AMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$522.37$5.0M324,443(I)

View →

Jul 28, 2026Jul 28 10:19 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$526.73$5.0M324,443(I)

View →

Jul 27, 2026Jul 28 1:36 AMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$530.42$5.0M324,443(I)

View →

Jul 24, 2026Jul 27 10:55 AMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$531.74$5.1M324,443(I)

View →

Jul 23, 2026Jul 24 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$528.58$5.0M324,443(I)

View →

Jul 22, 2026Jul 23 8:36 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$530.57$5.0M324,443(I)

View →

Jul 21, 2026Jul 22 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Sale
9,500$532.24$5.1M324,443(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2023Feb 26 9:30 PMJames EdgemondCFO AND TREASURER
Grant/Award
77,648$217.5010,380(D)

View →

Feb 25, 2026Feb 25 9:31 PMChristopher CauseyDirector
Option Exercise
1,000$119.766,320(D)

View →

Feb 23, 2026Feb 24 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,440$146.030(I)

View →

Feb 19, 2026Feb 19 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0341,800(D)

View →

Feb 17, 2026Feb 18 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.035,065(I)

View →

Feb 9, 2026Feb 10 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0312,940(I)

View →

Feb 5, 2026Feb 5 9:31 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0350,100(D)

View →

Feb 2, 2026Feb 3 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0320,815(I)

View →

Jan 26, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
22,500$146.0328,690(I)

View →

Jan 20, 2026Jan 28 9:31 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
7,875$146.0336,565(I)

View →

Jan 20, 2026Jan 28 9:30 PMMichael BenkowitzPRESIDENT AND COO
Option Exercise
14,625$146.0367,875(I)

View →

Jan 21, 2026Jan 23 9:32 PMKevin TraceyDirector
Grant/Award
1,220—1,220(D)

View →

← Previous

Page 13 of 13